help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heubi, J. E.
Right arrow Articles by Matthews, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heubi, J. E.
Right arrow Articles by Matthews, D. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL

Journal of Clinical Endocrinology & Metabolism, Vol 57, 885-891, Copyright © 1983 by Endocrine Society


ARTICLES

The role of human growth hormone in the regulation of cholesterol and bile acid metabolism

JE Heubi, S Burstein, MA Sperling, D Gregg, MT Subbiah and DE Matthews

Cholesterol and bile acid metabolism was studied in 16 children with human GH (hGH) deficiency (11 with isolated hGH deficiency and 5 with multiple trophic hormone deficiency) before and after 6 months of hGH therapy. We measured plasma lipid concentrations, biliary lipid composition, and cholesterol saturation indices; calculated the bile acid pool size measured by the isotopic dilution technique using the stable isotope chenodeoxycholic-[11,12-d2] acid; and measured cholesterol and bile acid synthetic rates by sterol balance techniques. In all 16 patients, plasmas lipid concentrations were unchanged after hGH therapy; total plasma cholesterol was 182 +/- 10 (+/-SEM) mg/dl before and 179 +/- 9 mg/dl after treatment, high density lipoprotein- cholesterol was 47 +/- 2 mg/dl before and 49 +/- 3 mg/dl after treatment, low density lipoprotein-cholesterol was 112 +/- 10 mg/dl before and 111 +/- 8 mg/dl after therapy, and triglyceride was 113 +/- 13 mg/dl before and 107 +/- 10 mg/dl after hGH therapy. Biliary lipid composition and cholesterol saturation in 10 patients were similar to those in controls and unchanged with hGH therapy. Cholesterol synthesis (n = 14) was unchanged (7.6 +/- 1.4 vs. 9.6 +/- 1.2 mg/kg X day); however, bile acid synthesis (n = 15) increased from 3.1 +/- 0.4 to 4.3 +/- 0.6 mg/kg X day (P less than 0.025) after therapy. The chenodeoxycholate pool size (n = 8) was significantly reduced (P less than 0.025) before hGH treatment (416 +/- 64 mg/m2) compared to that in controls (617 +/- 45 mg/m2) and increased to 620 +/- 72 mg/m2 after hGH therapy (P less than 0.05). Chenodeoxycholate pool size expansion during hGH therapy was, at least in part, caused by an increase in hepatic bile acid synthesis. These findings suggest that hGH may indirectly modulate cholesterol metabolism through regulation of hepatic cholesterol 7 alpha-hydroxylase activity, the rate-limiting enzyme of bile acid synthesis.


This article has been cited by other articles:


Home page
GutHome page
A F Hofmann
Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones
Gut, May 1, 2005; 54(5): 575 - 578.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Tollet-Egnell, A. Flores-Morales, N. Ståhlberg, R. L. Malek, N. Lee, and G. Norstedt
Gene Expression Profile of the Aging Process in Rat Liver: Normalizing Effects of Growth Hormone Replacement
Mol. Endocrinol., February 1, 2001; 15(2): 308 - 318.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
R. D. Steiner, L. M. Linck, D. P. Flavell, D. S. Lin, and W. E. Connor
Sterol balance in the Smith-Lemli-Opitz syndrome: reduction in whole body cholesterol synthesis and normal bile acid production
J. Lipid Res., September 1, 2000; 41(9): 1437 - 1447.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Leonsson, J. Oscarsson, I. Bosaeus, B. K. Lundgren, G. Johannsson, O. Wiklund, and B. A. Bengtsson
Growth Hormone (GH) Therapy in GH-Deficient Adults Influences the Response to a Dietary Load of Cholesterol and Saturated Fat in Terms of Cholesterol Synthesis, But Not Serum Low Density Lipoprotein Cholesterol Levels
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1296 - 1303.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Kuromaru, H. Kohno, N. Ueyama, H. M. S. Hassan, S. Honda, and T. Hara
Long-Term Prospective Study of Body Composition and Lipid Profiles during and after Growth Hormone (GH) Treatment in Children with GH Deficiency: Gender-Specific Metabolic Effects
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3890 - 3896.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society